gabapentin has been researched along with myelin basic protein in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araújo, CV; Brito, GAC; Câmara, CC; de Sousa, KKO; Martinez, AMB; Mendonça, FE; Mietto, BS; Oriá, RB; Raposo, RDS; Vale, ML | 1 |
| Angert, M; Chernov, AV; Dolkas, J; Eddinger, KA; Ko, JS; Shubayev, VI; Strongin, AY; Yaksh, TL | 1 |
| Arslantas, A; Aydin, HE; Baycu, C; Bektur, E; Kocman, AE; Kose, A; Ozbek, Z; Ozkara, E; Sahin, E; Vural, M | 1 |
3 other study(ies) available for gabapentin and myelin basic protein
| Article | Year |
|---|---|
Gabapentin attenuates neuropathic pain and improves nerve myelination after chronic sciatic constriction in rats.
Topics: Amines; Animals; Anticonvulsants; Constriction, Pathologic; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Male; Myelin Basic Protein; Nerve Regeneration; Neuralgia; Rats, Wistar; Sciatic Nerve | 2015 |
Spinal activity of interleukin 6 mediates myelin basic protein-induced allodynia.
Topics: Amines; Animals; Calcium Channel Blockers; Cyclohexanecarboxylic Acids; Cyclooxygenase Inhibitors; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Genomics; Hyperalgesia; Interleukin-6; Ketorolac; Lidocaine; Myelin Basic Protein; Peptide Fragments; Rats; Rats, Nude; Rats, Sprague-Dawley; Sciatic Nerve; Spinal Cord; Voltage-Gated Sodium Channel Blockers | 2016 |
Neuroprotective Effect of Genistein in Peripheral Nerve Injury.
Topics: Amines; Animals; Anti-Inflammatory Agents; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; GAP-43 Protein; Genistein; Interleukin-1beta; Male; Myelin Basic Protein; Nerve Crush; Neuralgia; Neuroprotective Agents; Peripheral Nerve Injuries; Rats; Rats, Sprague-Dawley; Recovery of Function; Sciatic Nerve; Sciatic Neuropathy; Treatment Outcome; Tumor Necrosis Factor-alpha | 2017 |